注射用ゲムシタビン粉末の世界市場インサイト及び予測 2027年

【英語タイトル】Global Gemcitabine Powder For Injection Market Insights and Forecast to 2027

QYResearchが出版した調査資料(QYR21DC05563)・商品コード:QYR21DC05563
・発行会社(調査会社):QYResearch
・発行日:2021年11月(※2024年版があります。お問い合わせください)
・ページ数:103
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥725,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥1,087,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,450,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートは注射用ゲムシタビン粉末の世界市場の現状について調査・分析し、2027年までの市場を予測しました。注射用ゲムシタビン粉末の世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模(200mg、1g、2g)、用途別市場規模(成人用、小児用、老人用)、主要地域別市場規模(北米・アメリカ、ヨーロッパ、アジア・日本・中国・インド、中南米、中東・アフリカ)、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。

・注射用ゲムシタビン粉末の世界市場概要
・メーカー別の競争状況、市場シェア
・注射用ゲムシタビン粉末の種類別市場規模:200mg、1g、2g
・注射用ゲムシタビン粉末の用途別市場規模:成人用、小児用、老人用
・北米の注射用ゲムシタビン粉末市場規模2016-2027:種類別、用途別、国別(アメリカ、カナダ)
・ヨーロッパの注射用ゲムシタビン粉末市場規模2016-2027:種類別、用途別、国別(ドイツ、フランス、イギリス)
・アジアの注射用ゲムシタビン粉末市場規模2016-2027:種類別、用途別、国別(日本、中国、インド、韓国)
・中南米の注射用ゲムシタビン粉末市場規模2016-2027:種類別、用途別、国別(メキシコ、ブラジル)
・中東・アフリカの注射用ゲムシタビン粉末市場規模2016-2027:種類別、用途別、国別(トルコ、サウジアラビア)
・企業情報:Accord Healthcare、Pfizer、Eli Lilly and Company、DRUG INTERNATIONAL LTD、Strides Pharma Science Limited、Getwell Pharmaceuticals、Jiangsu Hansoh Pharmaceutical Group、Harbin Pharmaceutical Group
・注射用ゲムシタビン粉末のバリューチェーン・販売チャネル分析
・注射用ゲムシタビン粉末の世界市場動向
【レポートの概要】

Gemcitabine Powder For Injection is used alone or with other treatments/medications to treat certain types of cancer (including breast, lung, ovarian, pancreatic). It is a chemotherapy drug that works by slowing or stopping the growth of cancer cells.

Market Analysis and Insights: Global Gemcitabine Powder For Injection Market
The global Gemcitabine Powder For Injection market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.

Global Gemcitabine Powder For Injection Scope and Segment
Gemcitabine Powder For Injection market is segmented by Dosage Type, and by Application. Players, stakeholders, and other participants in the global Gemcitabine Powder For Injection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Dosage Type and by Application for the period 2016-2027.

Segment by Dosage Type
200 mg
1 g
2 g

Segment by Application
Adult Use
Pediatric Use
Geriatric Use

By Company
Accord Healthcare
Pfizer
Eli Lilly and Company
DRUG INTERNATIONAL LTD
Strides Pharma Science Limited
Getwell Pharmaceuticals
Jiangsu Hansoh Pharmaceutical Group
Harbin Pharmaceutical Group

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

【レポートの目次】

1 Study Coverage
1.1 Gemcitabine Powder For Injection Product Introduction
1.2 Market by Dosage Type
1.2.1 Global Gemcitabine Powder For Injection Market Size Growth Rate by Dosage Type
1.2.2 200 mg
1.2.3 1 g
1.2.4 2 g
1.3 Market by Application
1.3.1 Global Gemcitabine Powder For Injection Market Size Growth Rate by Application
1.3.2 Adult Use
1.3.3 Pediatric Use
1.3.4 Geriatric Use
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Gemcitabine Powder For Injection Sales Estimates and Forecasts 2016-2027
2.2 Global Gemcitabine Powder For Injection Revenue Estimates and Forecasts 2016-2027
2.3 Global Gemcitabine Powder For Injection Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Gemcitabine Powder For Injection Regions by Sales
2.4.1 Global Top Gemcitabine Powder For Injection Regions by Sales (2016-2021)
2.4.2 Global Top Gemcitabine Powder For Injection Regions by Sales (2022-2027)
2.5 Global Top Gemcitabine Powder For Injection Regions by Revenue
2.5.1 Global Top Gemcitabine Powder For Injection Regions by Revenue (2016-2021)
2.5.2 Global Top Gemcitabine Powder For Injection Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa

3 Competition by Manufacturers
3.1 Global Gemcitabine Powder For Injection Sales by Manufacturers
3.1.1 Global Top Gemcitabine Powder For Injection Manufacturers by Sales (2016-2021)
3.1.2 Global Top Gemcitabine Powder For Injection Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Gemcitabine Powder For Injection Sales in 2020
3.2 Global Gemcitabine Powder For Injection Revenue by Manufacturers
3.2.1 Global Top Gemcitabine Powder For Injection Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Gemcitabine Powder For Injection Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Gemcitabine Powder For Injection Revenue in 2020
3.3 Global Gemcitabine Powder For Injection Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Gemcitabine Powder For Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Gemcitabine Powder For Injection Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Gemcitabine Powder For Injection Sales by Dosage Type
4.1.1 Global Gemcitabine Powder For Injection Historical Sales by Dosage Type (2016-2021)
4.1.2 Global Gemcitabine Powder For Injection Forecasted Sales by Dosage Type (2022-2027)
4.1.3 Global Gemcitabine Powder For Injection Sales Market Share by Dosage Type (2016-2027)
4.2 Global Gemcitabine Powder For Injection Revenue by Dosage Type
4.2.1 Global Gemcitabine Powder For Injection Historical Revenue by Dosage Type (2016-2021)
4.2.2 Global Gemcitabine Powder For Injection Forecasted Revenue by Dosage Type (2022-2027)
4.2.3 Global Gemcitabine Powder For Injection Revenue Market Share by Dosage Type (2016-2027)
4.3 Global Gemcitabine Powder For Injection Price by Dosage Type
4.3.1 Global Gemcitabine Powder For Injection Price by Dosage Type (2016-2021)
4.3.2 Global Gemcitabine Powder For Injection Price Forecast by Dosage Type (2022-2027)

5 Market Size by Application
5.1 Global Gemcitabine Powder For Injection Sales by Application
5.1.1 Global Gemcitabine Powder For Injection Historical Sales by Application (2016-2021)
5.1.2 Global Gemcitabine Powder For Injection Forecasted Sales by Application (2022-2027)
5.1.3 Global Gemcitabine Powder For Injection Sales Market Share by Application (2016-2027)
5.2 Global Gemcitabine Powder For Injection Revenue by Application
5.2.1 Global Gemcitabine Powder For Injection Historical Revenue by Application (2016-2021)
5.2.2 Global Gemcitabine Powder For Injection Forecasted Revenue by Application (2022-2027)
5.2.3 Global Gemcitabine Powder For Injection Revenue Market Share by Application (2016-2027)
5.3 Global Gemcitabine Powder For Injection Price by Application
5.3.1 Global Gemcitabine Powder For Injection Price by Application (2016-2021)
5.3.2 Global Gemcitabine Powder For Injection Price Forecast by Application (2022-2027)

6 North America
6.1 North America Gemcitabine Powder For Injection Market Size by Dosage Type
6.1.1 North America Gemcitabine Powder For Injection Sales by Dosage Type (2016-2027)
6.1.2 North America Gemcitabine Powder For Injection Revenue by Dosage Type (2016-2027)
6.2 North America Gemcitabine Powder For Injection Market Size by Application
6.2.1 North America Gemcitabine Powder For Injection Sales by Application (2016-2027)
6.2.2 North America Gemcitabine Powder For Injection Revenue by Application (2016-2027)
6.3 North America Gemcitabine Powder For Injection Market Size by Country
6.3.1 North America Gemcitabine Powder For Injection Sales by Country (2016-2027)
6.3.2 North America Gemcitabine Powder For Injection Revenue by Country (2016-2027)
6.3.3 United States
6.3.4 Canada

7 Europe
7.1 Europe Gemcitabine Powder For Injection Market Size by Dosage Type
7.1.1 Europe Gemcitabine Powder For Injection Sales by Dosage Type (2016-2027)
7.1.2 Europe Gemcitabine Powder For Injection Revenue by Dosage Type (2016-2027)
7.2 Europe Gemcitabine Powder For Injection Market Size by Application
7.2.1 Europe Gemcitabine Powder For Injection Sales by Application (2016-2027)
7.2.2 Europe Gemcitabine Powder For Injection Revenue by Application (2016-2027)
7.3 Europe Gemcitabine Powder For Injection Market Size by Country
7.3.1 Europe Gemcitabine Powder For Injection Sales by Country (2016-2027)
7.3.2 Europe Gemcitabine Powder For Injection Revenue by Country (2016-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia

8 Asia Pacific
8.1 Asia Pacific Gemcitabine Powder For Injection Market Size by Dosage Type
8.1.1 Asia Pacific Gemcitabine Powder For Injection Sales by Dosage Type (2016-2027)
8.1.2 Asia Pacific Gemcitabine Powder For Injection Revenue by Dosage Type (2016-2027)
8.2 Asia Pacific Gemcitabine Powder For Injection Market Size by Application
8.2.1 Asia Pacific Gemcitabine Powder For Injection Sales by Application (2016-2027)
8.2.2 Asia Pacific Gemcitabine Powder For Injection Revenue by Application (2016-2027)
8.3 Asia Pacific Gemcitabine Powder For Injection Market Size by Region
8.3.1 Asia Pacific Gemcitabine Powder For Injection Sales by Region (2016-2027)
8.3.2 Asia Pacific Gemcitabine Powder For Injection Revenue by Region (2016-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia

9 Latin America
9.1 Latin America Gemcitabine Powder For Injection Market Size by Dosage Type
9.1.1 Latin America Gemcitabine Powder For Injection Sales by Dosage Type (2016-2027)
9.1.2 Latin America Gemcitabine Powder For Injection Revenue by Dosage Type (2016-2027)
9.2 Latin America Gemcitabine Powder For Injection Market Size by Application
9.2.1 Latin America Gemcitabine Powder For Injection Sales by Application (2016-2027)
9.2.2 Latin America Gemcitabine Powder For Injection Revenue by Application (2016-2027)
9.3 Latin America Gemcitabine Powder For Injection Market Size by Country
9.3.1 Latin America Gemcitabine Powder For Injection Sales by Country (2016-2027)
9.3.2 Latin America Gemcitabine Powder For Injection Revenue by Country (2016-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Gemcitabine Powder For Injection Market Size by Dosage Type
10.1.1 Middle East and Africa Gemcitabine Powder For Injection Sales by Dosage Type (2016-2027)
10.1.2 Middle East and Africa Gemcitabine Powder For Injection Revenue by Dosage Type (2016-2027)
10.2 Middle East and Africa Gemcitabine Powder For Injection Market Size by Application
10.2.1 Middle East and Africa Gemcitabine Powder For Injection Sales by Application (2016-2027)
10.2.2 Middle East and Africa Gemcitabine Powder For Injection Revenue by Application (2016-2027)
10.3 Middle East and Africa Gemcitabine Powder For Injection Market Size by Country
10.3.1 Middle East and Africa Gemcitabine Powder For Injection Sales by Country (2016-2027)
10.3.2 Middle East and Africa Gemcitabine Powder For Injection Revenue by Country (2016-2027)
10.3.3 Turkey
10.3.4 Saudi Arabia

11 Company Profiles
11.1 Accord Healthcare
11.1.1 Accord Healthcare Corporation Information
11.1.2 Accord Healthcare Overview
11.1.3 Accord Healthcare Gemcitabine Powder For Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Accord Healthcare Gemcitabine Powder For Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Accord Healthcare Recent Developments
11.2 Pfizer
11.2.1 Pfizer Corporation Information
11.2.2 Pfizer Overview
11.2.3 Pfizer Gemcitabine Powder For Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Pfizer Gemcitabine Powder For Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Pfizer Recent Developments
11.3 Eli Lilly and Company
11.3.1 Eli Lilly and Company Corporation Information
11.3.2 Eli Lilly and Company Overview
11.3.3 Eli Lilly and Company Gemcitabine Powder For Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Eli Lilly and Company Gemcitabine Powder For Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Eli Lilly and Company Recent Developments
11.4 DRUG INTERNATIONAL LTD
11.4.1 DRUG INTERNATIONAL LTD Corporation Information
11.4.2 DRUG INTERNATIONAL LTD Overview
11.4.3 DRUG INTERNATIONAL LTD Gemcitabine Powder For Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 DRUG INTERNATIONAL LTD Gemcitabine Powder For Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 DRUG INTERNATIONAL LTD Recent Developments
11.5 Strides Pharma Science Limited
11.5.1 Strides Pharma Science Limited Corporation Information
11.5.2 Strides Pharma Science Limited Overview
11.5.3 Strides Pharma Science Limited Gemcitabine Powder For Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Strides Pharma Science Limited Gemcitabine Powder For Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Strides Pharma Science Limited Recent Developments
11.6 Getwell Pharmaceuticals
11.6.1 Getwell Pharmaceuticals Corporation Information
11.6.2 Getwell Pharmaceuticals Overview
11.6.3 Getwell Pharmaceuticals Gemcitabine Powder For Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Getwell Pharmaceuticals Gemcitabine Powder For Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Getwell Pharmaceuticals Recent Developments
11.7 Jiangsu Hansoh Pharmaceutical Group
11.7.1 Jiangsu Hansoh Pharmaceutical Group Corporation Information
11.7.2 Jiangsu Hansoh Pharmaceutical Group Overview
11.7.3 Jiangsu Hansoh Pharmaceutical Group Gemcitabine Powder For Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 Jiangsu Hansoh Pharmaceutical Group Gemcitabine Powder For Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Jiangsu Hansoh Pharmaceutical Group Recent Developments
11.8 Harbin Pharmaceutical Group
11.8.1 Harbin Pharmaceutical Group Corporation Information
11.8.2 Harbin Pharmaceutical Group Overview
11.8.3 Harbin Pharmaceutical Group Gemcitabine Powder For Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.8.4 Harbin Pharmaceutical Group Gemcitabine Powder For Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Harbin Pharmaceutical Group Recent Developments

12 Value Chain and Sales Channels Analysis
12.1 Gemcitabine Powder For Injection Value Chain Analysis
12.2 Gemcitabine Powder For Injection Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Gemcitabine Powder For Injection Production Mode & Process
12.4 Gemcitabine Powder For Injection Sales and Marketing
12.4.1 Gemcitabine Powder For Injection Sales Channels
12.4.2 Gemcitabine Powder For Injection Distributors
12.5 Gemcitabine Powder For Injection Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Gemcitabine Powder For Injection Industry Trends
13.2 Gemcitabine Powder For Injection Market Drivers
13.3 Gemcitabine Powder For Injection Market Challenges
13.4 Gemcitabine Powder For Injection Market Restraints

14 Key Findings in The Global Gemcitabine Powder For Injection Study

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Gemcitabine Powder For Injection Market Size Growth Rate by Dosage Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of 200 mg
Table 3. Major Manufacturers of 1 g
Table 4. Major Manufacturers of 2 g
Table 5. Global Gemcitabine Powder For Injection Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 6. Global Gemcitabine Powder For Injection Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 7. Global Gemcitabine Powder For Injection Sales by Region (2016-2021) & (Ton)
Table 8. Global Gemcitabine Powder For Injection Sales Market Share by Region (2016-2021)
Table 9. Global Gemcitabine Powder For Injection Sales by Region (2022-2027) & (Ton)
Table 10. Global Gemcitabine Powder For Injection Sales Market Share by Region (2022-2027)
Table 11. Global Gemcitabine Powder For Injection Revenue by Region (2016-2021) & (US$ Million)
Table 12. Global Gemcitabine Powder For Injection Revenue Market Share by Region (2016-2021)
Table 13. Global Gemcitabine Powder For Injection Revenue by Region (2022-2027) & (US$ Million)
Table 14. Global Gemcitabine Powder For Injection Revenue Market Share by Region (2022-2027)
Table 15. Global Gemcitabine Powder For Injection Sales by Manufacturers (2016-2021) & (Ton)
Table 16. Global Gemcitabine Powder For Injection Sales Share by Manufacturers (2016-2021)
Table 17. Global Gemcitabine Powder For Injection Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 18. Global Gemcitabine Powder For Injection Revenue Share by Manufacturers (2016-2021)
Table 19. Gemcitabine Powder For Injection Price by Manufacturers 2016-2021 (US$/Kg)
Table 20. Global Gemcitabine Powder For Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Gemcitabine Powder For Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gemcitabine Powder For Injection as of 2020)
Table 22. Gemcitabine Powder For Injection Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Gemcitabine Powder For Injection Product Offered
Table 24. Date of Manufacturers Enter into Gemcitabine Powder For Injection Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Gemcitabine Powder For Injection Sales by Dosage Type (2016-2021) & (Ton)
Table 27. Global Gemcitabine Powder For Injection Sales by Dosage Type (2022-2027) & (Ton)
Table 28. Global Gemcitabine Powder For Injection Sales Share by Dosage Type (2016-2021)
Table 29. Global Gemcitabine Powder For Injection Sales Share by Dosage Type (2022-2027)
Table 30. Global Gemcitabine Powder For Injection Revenue by Dosage Type (2016-2021) & (US$ Million)
Table 31. Global Gemcitabine Powder For Injection Revenue by Dosage Type (2022-2027) & (US$ Million)
Table 32. Global Gemcitabine Powder For Injection Revenue Share by Dosage Type (2016-2021)
Table 33. Global Gemcitabine Powder For Injection Revenue Share by Dosage Type (2022-2027)
Table 34. Gemcitabine Powder For Injection Price by Dosage Type (2016-2021) & (US$/Kg)
Table 35. Global Gemcitabine Powder For Injection Price Forecast by Dosage Type (2022-2027) & (US$/Kg)
Table 36. Global Gemcitabine Powder For Injection Sales by Application (2016-2021) & (Ton)
Table 37. Global Gemcitabine Powder For Injection Sales by Application (2022-2027) & (Ton)
Table 38. Global Gemcitabine Powder For Injection Sales Share by Application (2016-2021)
Table 39. Global Gemcitabine Powder For Injection Sales Share by Application (2022-2027)
Table 40. Global Gemcitabine Powder For Injection Revenue by Application (2016-2021) & (US$ Million)
Table 41. Global Gemcitabine Powder For Injection Revenue by Application (2022-2027) & (US$ Million)
Table 42. Global Gemcitabine Powder For Injection Revenue Share by Application (2016-2021)
Table 43. Global Gemcitabine Powder For Injection Revenue Share by Application (2022-2027)
Table 44. Gemcitabine Powder For Injection Price by Application (2016-2021) & (US$/Kg)
Table 45. Global Gemcitabine Powder For Injection Price Forecast by Application (2022-2027) & (US$/Kg)
Table 46. North America Gemcitabine Powder For Injection Sales by Dosage Type (2016-2021) & (Ton)
Table 47. North America Gemcitabine Powder For Injection Sales by Dosage Type (2022-2027) & (Ton)
Table 48. North America Gemcitabine Powder For Injection Revenue by Dosage Type (2016-2021) & (US$ Million)
Table 49. North America Gemcitabine Powder For Injection Revenue by Dosage Type (2022-2027) & (US$ Million)
Table 50. North America Gemcitabine Powder For Injection Sales by Application (2016-2021) & (Ton)
Table 51. North America Gemcitabine Powder For Injection Sales by Application (2022-2027) & (Ton)
Table 52. North America Gemcitabine Powder For Injection Revenue by Application (2016-2021) & (US$ Million)
Table 53. North America Gemcitabine Powder For Injection Revenue by Application (2022-2027) & (US$ Million)
Table 54. North America Gemcitabine Powder For Injection Sales by Country (2016-2021) & (Ton)
Table 55. North America Gemcitabine Powder For Injection Sales by Country (2022-2027) & (Ton)
Table 56. North America Gemcitabine Powder For Injection Revenue by Country (2016-2021) & (US$ Million)
Table 57. North America Gemcitabine Powder For Injection Revenue by Country (2022-2027) & (US$ Million)
Table 58. Europe Gemcitabine Powder For Injection Sales by Dosage Type (2016-2021) & (Ton)
Table 59. Europe Gemcitabine Powder For Injection Sales by Dosage Type (2022-2027) & (Ton)
Table 60. Europe Gemcitabine Powder For Injection Revenue by Dosage Type (2016-2021) & (US$ Million)
Table 61. Europe Gemcitabine Powder For Injection Revenue by Dosage Type (2022-2027) & (US$ Million)
Table 62. Europe Gemcitabine Powder For Injection Sales by Application (2016-2021) & (Ton)
Table 63. Europe Gemcitabine Powder For Injection Sales by Application (2022-2027) & (Ton)
Table 64. Europe Gemcitabine Powder For Injection Revenue by Application (2016-2021) & (US$ Million)
Table 65. Europe Gemcitabine Powder For Injection Revenue by Application (2022-2027) & (US$ Million)
Table 66. Europe Gemcitabine Powder For Injection Sales by Country (2016-2021) & (Ton)
Table 67. Europe Gemcitabine Powder For Injection Sales by Country (2022-2027) & (Ton)
Table 68. Europe Gemcitabine Powder For Injection Revenue by Country (2016-2021) & (US$ Million)
Table 69. Europe Gemcitabine Powder For Injection Revenue by Country (2022-2027) & (US$ Million)
Table 70. Asia Pacific Gemcitabine Powder For Injection Sales by Dosage Type (2016-2021) & (Ton)
Table 71. Asia Pacific Gemcitabine Powder For Injection Sales by Dosage Type (2022-2027) & (Ton)
Table 72. Asia Pacific Gemcitabine Powder For Injection Revenue by Dosage Type (2016-2021) & (US$ Million)
Table 73. Asia Pacific Gemcitabine Powder For Injection Revenue by Dosage Type (2022-2027) & (US$ Million)
Table 74. Asia Pacific Gemcitabine Powder For Injection Sales by Application (2016-2021) & (Ton)
Table 75. Asia Pacific Gemcitabine Powder For Injection Sales by Application (2022-2027) & (Ton)
Table 76. Asia Pacific Gemcitabine Powder For Injection Revenue by Application (2016-2021) & (US$ Million)
Table 77. Asia Pacific Gemcitabine Powder For Injection Revenue by Application (2022-2027) & (US$ Million)
Table 78. Asia Pacific Gemcitabine Powder For Injection Sales by Region (2016-2021) & (Ton)
Table 79. Asia Pacific Gemcitabine Powder For Injection Sales by Region (2022-2027) & (Ton)
Table 80. Asia Pacific Gemcitabine Powder For Injection Revenue by Region (2016-2021) & (US$ Million)
Table 81. Asia Pacific Gemcitabine Powder For Injection Revenue by Region (2022-2027) & (US$ Million)
Table 82. Latin America Gemcitabine Powder For Injection Sales by Dosage Type (2016-2021) & (Ton)
Table 83. Latin America Gemcitabine Powder For Injection Sales by Dosage Type (2022-2027) & (Ton)
Table 84. Latin America Gemcitabine Powder For Injection Revenue by Dosage Type (2016-2021) & (US$ Million)
Table 85. Latin America Gemcitabine Powder For Injection Revenue by Dosage Type (2022-2027) & (US$ Million)
Table 86. Latin America Gemcitabine Powder For Injection Sales by Application (2016-2021) & (Ton)
Table 87. Latin America Gemcitabine Powder For Injection Sales by Application (2022-2027) & (Ton)
Table 88. Latin America Gemcitabine Powder For Injection Revenue by Application (2016-2021) & (US$ Million)
Table 89. Latin America Gemcitabine Powder For Injection Revenue by Application (2022-2027) & (US$ Million)
Table 90. Latin America Gemcitabine Powder For Injection Sales by Country (2016-2021) & (Ton)
Table 91. Latin America Gemcitabine Powder For Injection Sales by Country (2022-2027) & (Ton)
Table 92. Latin America Gemcitabine Powder For Injection Revenue by Country (2016-2021) & (US$ Million)
Table 93. Latin America Gemcitabine Powder For Injection Revenue by Country (2022-2027) & (US$ Million)
Table 94. Middle East and Africa Gemcitabine Powder For Injection Sales by Dosage Type (2016-2021) & (Ton)
Table 95. Middle East and Africa Gemcitabine Powder For Injection Sales by Dosage Type (2022-2027) & (Ton)
Table 96. Middle East and Africa Gemcitabine Powder For Injection Revenue by Dosage Type (2016-2021) & (US$ Million)
Table 97. Middle East and Africa Gemcitabine Powder For Injection Revenue by Dosage Type (2022-2027) & (US$ Million)
Table 98. Middle East and Africa Gemcitabine Powder For Injection Sales by Application (2016-2021) & (Ton)
Table 99. Middle East and Africa Gemcitabine Powder For Injection Sales by Application (2022-2027) & (Ton)
Table 100. Middle East and Africa Gemcitabine Powder For Injection Revenue by Application (2016-2021) & (US$ Million)
Table 101. Middle East and Africa Gemcitabine Powder For Injection Revenue by Application (2022-2027) & (US$ Million)
Table 102. Middle East and Africa Gemcitabine Powder For Injection Sales by Country (2016-2021) & (Ton)
Table 103. Middle East and Africa Gemcitabine Powder For Injection Sales by Country (2022-2027) & (Ton)
Table 104. Middle East and Africa Gemcitabine Powder For Injection Revenue by Country (2016-2021) & (US$ Million)
Table 105. Middle East and Africa Gemcitabine Powder For Injection Revenue by Country (2022-2027) & (US$ Million)
Table 106. Accord Healthcare Corporation Information
Table 107. Accord Healthcare Description and Major Businesses
Table 108. Accord Healthcare Gemcitabine Powder For Injection Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2016-2021)
Table 109. Accord Healthcare Gemcitabine Powder For Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. Accord Healthcare Recent Developments
Table 111. Pfizer Corporation Information
Table 112. Pfizer Description and Major Businesses
Table 113. Pfizer Gemcitabine Powder For Injection Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2016-2021)
Table 114. Pfizer Gemcitabine Powder For Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Pfizer Recent Developments
Table 116. Eli Lilly and Company Corporation Information
Table 117. Eli Lilly and Company Description and Major Businesses
Table 118. Eli Lilly and Company Gemcitabine Powder For Injection Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2016-2021)
Table 119. Eli Lilly and Company Gemcitabine Powder For Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Eli Lilly and Company Recent Developments
Table 121. DRUG INTERNATIONAL LTD Corporation Information
Table 122. DRUG INTERNATIONAL LTD Description and Major Businesses
Table 123. DRUG INTERNATIONAL LTD Gemcitabine Powder For Injection Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2016-2021)
Table 124. DRUG INTERNATIONAL LTD Gemcitabine Powder For Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. DRUG INTERNATIONAL LTD Recent Developments
Table 126. Strides Pharma Science Limited Corporation Information
Table 127. Strides Pharma Science Limited Description and Major Businesses
Table 128. Strides Pharma Science Limited Gemcitabine Powder For Injection Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2016-2021)
Table 129. Strides Pharma Science Limited Gemcitabine Powder For Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Strides Pharma Science Limited Recent Developments
Table 131. Getwell Pharmaceuticals Corporation Information
Table 132. Getwell Pharmaceuticals Description and Major Businesses
Table 133. Getwell Pharmaceuticals Gemcitabine Powder For Injection Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2016-2021)
Table 134. Getwell Pharmaceuticals Gemcitabine Powder For Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. Getwell Pharmaceuticals Recent Developments
Table 136. Jiangsu Hansoh Pharmaceutical Group Corporation Information
Table 137. Jiangsu Hansoh Pharmaceutical Group Description and Major Businesses
Table 138. Jiangsu Hansoh Pharmaceutical Group Gemcitabine Powder For Injection Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2016-2021)
Table 139. Jiangsu Hansoh Pharmaceutical Group Gemcitabine Powder For Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. Jiangsu Hansoh Pharmaceutical Group Recent Developments
Table 141. Harbin Pharmaceutical Group Corporation Information
Table 142. Harbin Pharmaceutical Group Description and Major Businesses
Table 143. Harbin Pharmaceutical Group Gemcitabine Powder For Injection Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2016-2021)
Table 144. Harbin Pharmaceutical Group Gemcitabine Powder For Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 145. Harbin Pharmaceutical Group Recent Developments
Table 146. Key Raw Materials Lists
Table 147. Raw Materials Key Suppliers Lists
Table 148. Gemcitabine Powder For Injection Distributors List
Table 149. Gemcitabine Powder For Injection Customers List
Table 150. Gemcitabine Powder For Injection Market Trends
Table 151. Gemcitabine Powder For Injection Market Drivers
Table 152. Gemcitabine Powder For Injection Market Challenges
Table 153. Gemcitabine Powder For Injection Market Restraints
Table 154. Research Programs/Design for This Report
Table 155. Key Data Information from Secondary Sources
Table 156. Key Data Information from Primary Sources
List of Figures
Figure 1. Gemcitabine Powder For Injection Product Picture
Figure 2. Global Gemcitabine Powder For Injection Market Share by Dosage Type in 2020 & 2027
Figure 3. 200 mg Product Picture
Figure 4. 1 g Product Picture
Figure 5. 2 g Product Picture
Figure 6. Global Gemcitabine Powder For Injection Market Share by Application in 2020 & 2027
Figure 7. Adult Use
Figure 8. Pediatric Use
Figure 9. Geriatric Use
Figure 10. Gemcitabine Powder For Injection Report Years Considered
Figure 11. Global Gemcitabine Powder For Injection Sales 2016-2027 (Ton)
Figure 12. Global Gemcitabine Powder For Injection Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Gemcitabine Powder For Injection Revenue 2016-2027 (US$ Million)
Figure 14. Global Gemcitabine Powder For Injection Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 15. Global Gemcitabine Powder For Injection Sales Market Share by Region (2016-2021)
Figure 16. Global Gemcitabine Powder For Injection Sales Market Share by Region (2022-2027)
Figure 17. North America Gemcitabine Powder For Injection Sales YoY (2016-2027) & (Ton)
Figure 18. North America Gemcitabine Powder For Injection Revenue YoY (2016-2027) & (US$ Million)
Figure 19. Europe Gemcitabine Powder For Injection Sales YoY (2016-2027) & (Ton)
Figure 20. Europe Gemcitabine Powder For Injection Revenue YoY (2016-2027) & (US$ Million)
Figure 21. Asia-Pacific Gemcitabine Powder For Injection Sales YoY (2016-2027) & (Ton)
Figure 22. Asia-Pacific Gemcitabine Powder For Injection Revenue YoY (2016-2027) & (US$ Million)
Figure 23. Latin America Gemcitabine Powder For Injection Sales YoY (2016-2027) & (Ton)
Figure 24. Latin America Gemcitabine Powder For Injection Revenue YoY (2016-2027) & (US$ Million)
Figure 25. Middle East & Africa Gemcitabine Powder For Injection Sales YoY (2016-2027) & (Ton)
Figure 26. Middle East & Africa Gemcitabine Powder For Injection Revenue YoY (2016-2027) & (US$ Million)
Figure 27. The Top 10 and Top 5 Players Market Share by Gemcitabine Powder For Injection Sales in 2020
Figure 28. The Top 10 and Top 5 Players Market Share by Gemcitabine Powder For Injection Revenue in 2020
Figure 29. Gemcitabine Powder For Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 30. Global Gemcitabine Powder For Injection Sales Market Share by Dosage Type (2016-2027)
Figure 31. Global Gemcitabine Powder For Injection Revenue Market Share by Dosage Type (2016-2027)
Figure 32. Global Gemcitabine Powder For Injection Sales Market Share by Application (2016-2027)
Figure 33. Global Gemcitabine Powder For Injection Revenue Market Share by Application (2016-2027)
Figure 34. North America Gemcitabine Powder For Injection Sales Market Share by Dosage Type (2016-2027)
Figure 35. North America Gemcitabine Powder For Injection Revenue Market Share by Dosage Type (2016-2027)
Figure 36. North America Gemcitabine Powder For Injection Sales Market Share by Application (2016-2027)
Figure 37. North America Gemcitabine Powder For Injection Revenue Market Share by Application (2016-2027)
Figure 38. North America Gemcitabine Powder For Injection Sales Share by Country (2016-2027)
Figure 39. North America Gemcitabine Powder For Injection Revenue Share by Country (2016-2027)
Figure 40. United States Gemcitabine Powder For Injection Revenue (2016-2027) & (US$ Million)
Figure 41. Canada Gemcitabine Powder For Injection Revenue (2016-2027) & (US$ Million)
Figure 42. Europe Gemcitabine Powder For Injection Sales Market Share by Dosage Type (2016-2027)
Figure 43. Europe Gemcitabine Powder For Injection Revenue Market Share by Dosage Type (2016-2027)
Figure 44. Europe Gemcitabine Powder For Injection Sales Market Share by Application (2016-2027)
Figure 45. Europe Gemcitabine Powder For Injection Revenue Market Share by Application (2016-2027)
Figure 46. Europe Gemcitabine Powder For Injection Sales Share by Country (2016-2027)
Figure 47. Europe Gemcitabine Powder For Injection Revenue Share by Country (2016-2027)
Figure 48. Germany Gemcitabine Powder For Injection Revenue (2016-2027) & (US$ Million)
Figure 49. France Gemcitabine Powder For Injection Revenue (2016-2027) & (US$ Million)
Figure 50. U.K. Gemcitabine Powder For Injection Revenue (2016-2027) & (US$ Million)
Figure 51. Italy Gemcitabine Powder For Injection Revenue (2016-2027) & (US$ Million)
Figure 52. Russia Gemcitabine Powder For Injection Revenue (2016-2027) & (US$ Million)
Figure 53. Asia Pacific Gemcitabine Powder For Injection Sales Market Share by Dosage Type (2016-2027)
Figure 54. Asia Pacific Gemcitabine Powder For Injection Revenue Market Share by Dosage Type (2016-2027)
Figure 55. Asia Pacific Gemcitabine Powder For Injection Sales Market Share by Application (2016-2027)
Figure 56. Asia Pacific Gemcitabine Powder For Injection Revenue Market Share by Application (2016-2027)
Figure 57. Asia Pacific Gemcitabine Powder For Injection Sales Share by Region (2016-2027)
Figure 58. Asia Pacific Gemcitabine Powder For Injection Revenue Share by Region (2016-2027)
Figure 59. China Gemcitabine Powder For Injection Revenue (2016-2027) & (US$ Million)
Figure 60. Japan Gemcitabine Powder For Injection Revenue (2016-2027) & (US$ Million)
Figure 61. South Korea Gemcitabine Powder For Injection Revenue (2016-2027) & (US$ Million)
Figure 62. India Gemcitabine Powder For Injection Revenue (2016-2027) & (US$ Million)
Figure 63. Australia Gemcitabine Powder For Injection Revenue (2016-2027) & (US$ Million)
Figure 64. China Taiwan Gemcitabine Powder For Injection Revenue (2016-2027) & (US$ Million)
Figure 65. Indonesia Gemcitabine Powder For Injection Revenue (2016-2027) & (US$ Million)
Figure 66. Thailand Gemcitabine Powder For Injection Revenue (2016-2027) & (US$ Million)
Figure 67. Malaysia Gemcitabine Powder For Injection Revenue (2016-2027) & (US$ Million)
Figure 68. Latin America Gemcitabine Powder For Injection Sales Market Share by Dosage Type (2016-2027)
Figure 69. Latin America Gemcitabine Powder For Injection Revenue Market Share by Dosage Type (2016-2027)
Figure 70. Latin America Gemcitabine Powder For Injection Sales Market Share by Application (2016-2027)
Figure 71. Latin America Gemcitabine Powder For Injection Revenue Market Share by Application (2016-2027)
Figure 72. Latin America Gemcitabine Powder For Injection Sales Share by Country (2016-2027)
Figure 73. Latin America Gemcitabine Powder For Injection Revenue Share by Country (2016-2027)
Figure 74. Mexico Gemcitabine Powder For Injection Revenue (2016-2027) & (US$ Million)
Figure 75. Brazil Gemcitabine Powder For Injection Revenue (2016-2027) & (US$ Million)
Figure 76. Argentina Gemcitabine Powder For Injection Revenue (2016-2027) & (US$ Million)
Figure 77. Middle East and Africa Gemcitabine Powder For Injection Sales Market Share by Dosage Type (2016-2027)
Figure 78. Middle East and Africa Gemcitabine Powder For Injection Revenue Market Share by Dosage Type (2016-2027)
Figure 79. Middle East and Africa Gemcitabine Powder For Injection Sales Market Share by Application (2016-2027)
Figure 80. Middle East and Africa Gemcitabine Powder For Injection Revenue Market Share by Application (2016-2027)
Figure 81. Middle East and Africa Gemcitabine Powder For Injection Sales Share by Country (2016-2027)
Figure 82. Middle East and Africa Gemcitabine Powder For Injection Revenue Share by Country (2016-2027)
Figure 83. Turkey Gemcitabine Powder For Injection Revenue (2016-2027) & (US$ Million)
Figure 84. Saudi Arabia Gemcitabine Powder For Injection Revenue (2016-2027) & (US$ Million)
Figure 85. UAE Gemcitabine Powder For Injection Revenue (2016-2027) & (US$ Million)
Figure 86. Gemcitabine Powder For Injection Value Chain
Figure 87. Gemcitabine Powder For Injection Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed


【掲載企業】

Accord Healthcare、Pfizer、Eli Lilly and Company、DRUG INTERNATIONAL LTD、Strides Pharma Science Limited、Getwell Pharmaceuticals、Jiangsu Hansoh Pharmaceutical Group、Harbin Pharmaceutical Group

★調査レポート[注射用ゲムシタビン粉末の世界市場インサイト及び予測 2027年] (コード:QYR21DC05563)販売に関する免責事項を必ずご確認ください。
★調査レポート[注射用ゲムシタビン粉末の世界市場インサイト及び予測 2027年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆